0001315863-15-000965.txt : 20151208 0001315863-15-000965.hdr.sgml : 20151208 20151208140737 ACCESSION NUMBER: 0001315863-15-000965 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20151208 DATE AS OF CHANGE: 20151208 EFFECTIVENESS DATE: 20151208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioPharma Credit Investments IV, S.a.r.l. CENTRAL INDEX KEY: 0001653577 IRS NUMBER: 000000000 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-252618 FILM NUMBER: 151274822 BUSINESS ADDRESS: STREET 1: 6, RUE EUGENE RUPPERT CITY: LUXEMBOURG STATE: N4 ZIP: L-2453 BUSINESS PHONE: 352 26 44 91 MAIL ADDRESS: STREET 1: 6, RUE EUGENE RUPPERT CITY: LUXEMBOURG STATE: N4 ZIP: L-2453 D 1 primary_doc.xml X0707 D LIVE 0001653577 BioPharma Credit Investments IV, S.a.r.l. 6, Rue Eugene Ruppert Luxembourg N4 LUXEMBOURG L-2453 352 26 44 91 LUXEMBOURG None None Other Luxembourg Limited Liability Company true 2015 Myla Tolentino 6, Rue Eugene Ruppert Luxembourg N4 LUXEMBOURG L-2453 Director Member of Board of Managers of Issuer Miroslava Jassova 6, Rue Eugene Ruppert Luxembourg N4 LUXEMBOURG L-2453 Director Member of Board of Managers of Issuer Martin Paul Galliver 6, Rue Eugene Ruppert Luxembourg N4 LUXEMBOURG L-2453 Director Member of Board of Managers of Issuer Pooled Investment Fund Other Investment Fund false Decline to Disclose 06b false true false true false 0 Indefinite 0 Indefinite false 0 0 0 0 The Investment Manager is entitled to a management fee which is fully discussed in Issuer's confidential offering materials. false BioPharma Credit Investments IV, S.a.r.l. /s/Martin Paul Galliver Martin Paul Galliver Member of Board of Managers of Issuer 2015-12-08